Layering too many DHT-inhibiting treatments can lead to excessively low DHT levels and associated side effects. — Whalespan
Layering too many DHT-inhibiting treatments can lead to excessively low DHT levels and associated side effects.
⚠ High risk
We can't find evidence that holds up here. Proponents are reasoning from mechanism or analogy rather than direct human data, and the most credible skeptics raise objections we can't dismiss.
✕NOTSUPPORTED
⚠
High-risk intervention — consult a physician before acting.Drug-drug interactions, dose-dependence, and screening contraindications apply.
“although anytime you're inhibiting a DHT pathway, or whether or not you're increasing or decreasing any hormone pathway for that matter, you want to be careful about layering in too many different treatments because you don't want your DHT level to go too low.”